Loredana Cifaldi

3.2k total citations · 1 hit paper
57 papers, 2.3k citations indexed

About

Loredana Cifaldi is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Loredana Cifaldi has authored 57 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Immunology, 25 papers in Oncology and 16 papers in Molecular Biology. Recurrent topics in Loredana Cifaldi's work include Immune Cell Function and Interaction (32 papers), T-cell and B-cell Immunology (12 papers) and Neuroblastoma Research and Treatments (11 papers). Loredana Cifaldi is often cited by papers focused on Immune Cell Function and Interaction (32 papers), T-cell and B-cell Immunology (12 papers) and Neuroblastoma Research and Treatments (11 papers). Loredana Cifaldi collaborates with scholars based in Italy, Albania and United States. Loredana Cifaldi's co-authors include Doriana Fruci, Franco Locatelli, Ombretta Melaiu, Valeria Lucarini, Renata Boldrini, Patrizio Giacomini, Matteo Forloni, Silvia Lorenzi, Raffaele Strippoli and Sonia Albini and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Loredana Cifaldi

56 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Influence of the Tumor Microenvironment on NK Cell Function in Solid Tumors

2020 312 citations Ombretta Melaiu, Valeria Lucarini et al. Frontiers in Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Loredana Cifaldi Italy	26	1.2k	800	782	404	291	57	2.3k
Tong Zhou United States	26	1.5k 1.3×	1.3k 1.6×	473 0.6×	338 0.8×	94 0.3×	68	2.9k
Laura S. Angelo United States	19	696 0.6×	981 1.2×	985 1.3×	294 0.7×	78 0.3×	29	2.1k
Michele Ardolino Canada	17	2.0k 1.7×	481 0.6×	1.4k 1.8×	193 0.5×	71 0.2×	31	2.7k
Masaki Inoue Japan	33	1.1k 0.9×	1.1k 1.4×	768 1.0×	368 0.9×	85 0.3×	93	3.2k
Shaohua Chen China	26	1.4k 1.2×	1.0k 1.3×	1.2k 1.5×	576 1.4×	67 0.2×	184	3.0k
Igor Espinoza‐Delgado United States	32	786 0.7×	1.7k 2.2×	959 1.2×	181 0.4×	131 0.5×	78	3.1k
Manjula Reddy United States	23	840 0.7×	737 0.9×	719 0.9×	222 0.5×	41 0.1×	39	2.0k
Alla Skapenko Germany	25	1.4k 1.1×	768 1.0×	532 0.7×	213 0.5×	32 0.1×	69	2.8k
Filippo Veglia United States	14	2.8k 2.4×	1.1k 1.4×	1.4k 1.8×	597 1.5×	47 0.2×	27	4.0k
Nicholas Borcherding United States	28	773 0.7×	1.3k 1.6×	923 1.2×	467 1.2×	40 0.1×	77	2.7k

Countries citing papers authored by Loredana Cifaldi

Since Specialization

Citations

This map shows the geographic impact of Loredana Cifaldi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Loredana Cifaldi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Loredana Cifaldi more than expected).

Fields of papers citing papers by Loredana Cifaldi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Loredana Cifaldi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Loredana Cifaldi. The network helps show where Loredana Cifaldi may publish in the future.

Co-authorship network of co-authors of Loredana Cifaldi

This figure shows the co-authorship network connecting the top 25 collaborators of Loredana Cifaldi. A scholar is included among the top collaborators of Loredana Cifaldi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Loredana Cifaldi. Loredana Cifaldi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lucarini, Valeria, Adele De Ninno, Luca Businaro, et al.. (2025). Immunogenic Cell Death Inducers in Cancer Immunotherapy to Turn Cold Tumors into Hot Tumors. International Journal of Molecular Sciences. 26(4). 1613–1613.

Lucarini, Valeria, Monica Benvenuto, Chiara Focaccetti, et al.. (2025). Combined IFN-γ and TNF-α treatment enhances the susceptibility of breast cancer cells and spheroids to Natural Killer cell-mediated killing. Cell Death and Disease. 16(1). 729–729. 1 indexed citations

Focaccetti, Chiara, Monica Benvenuto, Valeria Lucarini, et al.. (2024). Bisphenol-A in Drinking Water Accelerates Mammary Cancerogenesis and Favors an Immunosuppressive Tumor Microenvironment in BALB–neuT Mice. International Journal of Molecular Sciences. 25(11). 6259–6259. 12 indexed citations

Infante, A J, Valeria Lucarini, Fernando De Maio, et al.. (2024). Polyphenols Regulate the Activity of Endocrine-Disrupting Chemicals, Having Both Positive and Negative Effects. SHILAP Revista de lepidopterología. 14(4). 1378–1405. 4 indexed citations

Pighi, Chiara, Maia De Luca, Sara Chiurchiù, et al.. (2024). Characterization of Natural Killer Cell Profile in a Cohort of Infected Pregnant Women and Their Babies and Its Relation to CMV Transmission. Viruses. 16(5). 780–780. 1 indexed citations

Pomella, Silvia, Ombretta Melaiu, Loredana Cifaldi, et al.. (2024). Biomarkers Identification in the Microenvironment of Oral Squamous Cell Carcinoma: A Systematic Review of Proteomic Studies. International Journal of Molecular Sciences. 25(16). 8929–8929. 4 indexed citations

Focaccetti, Chiara, Camilla Palumbo, Monica Benvenuto, et al.. (2023). The Combination of Bioavailable Concentrations of Curcumin and Resveratrol Shapes Immune Responses While Retaining the Ability to Reduce Cancer Cell Survival. International Journal of Molecular Sciences. 25(1). 232–232. 16 indexed citations

Focaccetti, Chiara, Monica Benvenuto, Chiara Pighi, et al.. (2022). DNAM-1-chimeric receptor-engineered NK cells, combined with Nutlin-3a, more effectively fight neuroblastoma cells in vitro: a proof-of-concept study. Frontiers in Immunology. 13. 886319–886319. 21 indexed citations

Focaccetti, Chiara, Annalisa Pezzolo, Marzia Ognibene, et al.. (2021). Enhancement of Neuroblastoma NK-Cell-Mediated Lysis through NF-kB p65 Subunit-Induced Expression of FAS and PVR, the Loss of Which Is Associated with Poor Patient Outcome. Cancers. 13(17). 4368–4368. 8 indexed citations

10.

Albonici, Loredana, Monica Benvenuto, Chiara Focaccetti, et al.. (2020). PlGF Immunological Impact during Pregnancy. International Journal of Molecular Sciences. 21(22). 8714–8714. 26 indexed citations

11.

Infante, Paola, Elisa Ferretti, Ombretta Melaiu, et al.. (2020). Nutlin-3a Enhances Natural Killer Cell–Mediated Killing of Neuroblastoma by Restoring p53-Dependent Expression of Ligands for NKG2D and DNAM-1 Receptors. Cancer Immunology Research. 9(2). 170–183. 34 indexed citations

12.

Cifaldi, Loredana, Margherita Doria, Nicola Cotugno, et al.. (2019). DNAM-1 Activating Receptor and Its Ligands: How Do Viruses Affect the NK Cell-Mediated Immune Surveillance during the Various Phases of Infection?. International Journal of Molecular Sciences. 20(15). 3715–3715. 40 indexed citations

13.

Ognibene, Marzia, et al.. (2018). Neuroblastoma Cell Lines Are Refractory to Genotoxic Drug-Mediated Induction of Ligands for NK Cell-Activating Receptors. Journal of Immunology Research. 2018. 1–10. 6 indexed citations

14.

Boldrini, Renata, Maria Debora De Pasquale, Ombretta Melaiu, et al.. (2018). Tumor-infiltrating T cells and PD-L1 expression in childhood malignant extracranial germ-cell tumors. OncoImmunology. 8(2). e1542245–e1542245. 26 indexed citations

15.

Melaiu, Ombretta, Annalisa Pezzolo, Aurora Castellano, et al.. (2017). MYCN is an immunosuppressive oncogene dampening the expression of ligands for NK-cell-activating receptors in human high-risk neuroblastoma. OncoImmunology. 6(6). 39 indexed citations

16.

Cifaldi, Loredana, Paolo Romania, Michela Falco, et al.. (2015). ERAP1 Regulates Natural Killer Cell Function by Controlling the Engagement of Inhibitory Receptors. Cancer Research. 75(5). 824–834. 53 indexed citations

17.

Cifaldi, Loredana, Elisa Lo Monaco, Matteo Forloni, et al.. (2011). Natural Killer Cells Efficiently Reject Lymphoma Silenced for the Endoplasmic Reticulum Aminopeptidase Associated with Antigen Processing. Cancer Research. 71(5). 1597–1606. 64 indexed citations

18.

Forloni, Matteo, Sonia Albini, Loredana Cifaldi, et al.. (2010). NF-κB, and not MYCN, Regulates MHC Class I and Endoplasmic Reticulum Aminopeptidases in Human Neuroblastoma Cells. Cancer Research. 70(3). 916–924. 62 indexed citations

19.

Carbone, Teresa, Francesca Nasorri, Davide Pennino, et al.. (2009). CD56highCD16−CD62L− NK Cells Accumulate in Allergic Contact Dermatitis and Contribute to the Expression of Allergic Responses. The Journal of Immunology. 184(2). 1102–1110. 67 indexed citations

20.

Gismondi, Angela, Jordan Jacobelli, Raffaele Strippoli, et al.. (2003). Proline-Rich Tyrosine Kinase 2 and Rac Activation by Chemokine and Integrin Receptors Controls NK Cell Transendothelial Migration. The Journal of Immunology. 170(6). 3065–3073. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact